Peritonitis carcinomatosa van colorectaal carcinoom : Nieuwe behandelmogelijkheden
(2015) In Nederlands Tijdschrift voor Geneeskunde 159(47).- Abstract
• Peritonitis carcinomatosa occurs in 10% of patients with colorectal carcinoma. • Compared with patients with lung and liver metastases, survival in patients with peritonitis carcinomatosa is worse if treated with systemic chemotherapy. However, treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) offers longer survival than systemic chemotherapy. • A Dutch registration study shows that the 3- and 5-year survival of patients treated with cytoreductive surgery and HIPEC had a 3-year survival of 46% and a 5-year survival of 31%. • Mortality and morbidity have dropped greatly due to standardisation of the intervention in accordance with the Dutch protocol.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/257039bc-15df-4a27-bb04-0f9b69d4ad8b
- author
- Verwaal, Victor J. LU ; De Hingh, Ignace H.J.T. and Boot, Henk
- alternative title
- Peritonitis carcinomatosa from colorectal carcinoma : New treatment options
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- in
- Nederlands Tijdschrift voor Geneeskunde
- volume
- 159
- issue
- 47
- article number
- A9319
- publisher
- Bohn Stafleu van Loghum
- external identifiers
-
- pmid:26556491
- scopus:84947749887
- ISSN
- 0028-2162
- language
- Dutch
- LU publication?
- no
- additional info
- Original language: Dutch
- id
- 257039bc-15df-4a27-bb04-0f9b69d4ad8b
- alternative location
- https://www.ntvg.nl/system/files/publications/a9319.pdf
- date added to LUP
- 2022-04-12 11:02:47
- date last changed
- 2024-01-06 23:40:12
@article{257039bc-15df-4a27-bb04-0f9b69d4ad8b, abstract = {{<p>• Peritonitis carcinomatosa occurs in 10% of patients with colorectal carcinoma. • Compared with patients with lung and liver metastases, survival in patients with peritonitis carcinomatosa is worse if treated with systemic chemotherapy. However, treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) offers longer survival than systemic chemotherapy. • A Dutch registration study shows that the 3- and 5-year survival of patients treated with cytoreductive surgery and HIPEC had a 3-year survival of 46% and a 5-year survival of 31%. • Mortality and morbidity have dropped greatly due to standardisation of the intervention in accordance with the Dutch protocol.</p>}}, author = {{Verwaal, Victor J. and De Hingh, Ignace H.J.T. and Boot, Henk}}, issn = {{0028-2162}}, language = {{dut}}, number = {{47}}, publisher = {{Bohn Stafleu van Loghum}}, series = {{Nederlands Tijdschrift voor Geneeskunde}}, title = {{Peritonitis carcinomatosa van colorectaal carcinoom : Nieuwe behandelmogelijkheden}}, url = {{https://www.ntvg.nl/system/files/publications/a9319.pdf}}, volume = {{159}}, year = {{2015}}, }